Weill Cornell Medicine has received a $1.4 million, four-year grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.

You don’t have to feel good about these reactions to a human tragedy to understand why anybody associated with the insurance ...

A newly developed approach can precisely produce four-stranded β-sheets through metal–peptide coordination, report ...